Showing results (11-20 of 20) with videos related to
Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
British Journal of Cancer|April 20, 2006
Epirubicin/paclitaxel/etoposide in extensive-stage small-cell lung cancer: a phase I-II studyC Tibaldi, T Prochilo, F Russo, et al.European Journal of Cancer (Oxford, England : 1990)|January 1, 1993
High dose-intensity chemotherapy, with accelerated cyclophosphamide-doxorubicin-etoposide and granulocyte-macrophage colony stimulating factor, in the treatment of small cell lung cancerA Ardizzoni, M Venturini, L Crinò, et al.British Journal of Cancer|February 1, 1994
Granulocyte-macrophage colony-stimulating factor (GM-CSF) allows acceleration and dose intensity increase of CEF chemotherapy: a randomised study in patients with advanced breast cancerA Ardizzoni, M Venturini, M R Sertoli, et al.British Journal of Cancer|January 1, 1995
Mitomycin-ifosfamide-cisplatinum (MIP) vs MIP-interferon vs cisplatinum-carboplatin in metastatic non-small-cell lung cancer: a FONICAP randomised phase II study. Italian Lung Cancer Task ForceA Ardizzoni, G F Addamo, E Baldini, et al.Cancer|November 15, 1993
Combination of chemotherapy and recombinant alpha-interferon in advanced non-small cell lung cancer. Multicentric Randomized FONICAP Trial Report. The Italian Lung Cancer Task ForceA Ardizzoni, F Salvati, R Rosso, et al.Tumori|July 30, 1999
The role of vindesine and lonidamine in the treatment of elderly patients with advanced non-small cell lung cancer: a phase III randomized FONICAP trial. Italian Lung Cancer Task ForceF De Marinis, M Rinaldi, A Ardizzoni, et al.British Journal of Cancer|September 1, 1996
Paclitaxel for malignant pleural mesothelioma: a phase II study of the EORTC Lung Cancer Cooperative GroupJ van Meerbeeck, C Debruyne, N van Zandwijk, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 17, 1998
Randomized study of paclitaxel-cisplatin versus cisplatin-teniposide in patients with advanced non-small-cell lung cancer. The European Organization for Research and Treatment of Cancer Lung Cancer Cooperative GroupG Giaccone, T A Splinter, C Debruyne, et al.American Journal of Clinical Oncology|February 22, 2000
Ambamustine in the second-line treatment of patients with small-cell lung cancer: a phase II Fonicap studyA Ardizzoni, G Antonelli, S Ricci, et al.British Journal of Cancer|July 2, 1998
Cisplatin-vindesine-mitomycin (MVP) vs cisplatin-ifosfamide-vinorelbine (PIN) vs carboplatin-vinorelbine (CaN) in patients with advanced non-small-cell lung cancer (NSCLC): a FONICAP randomized phase II study. Italian Lung Cancer Task Force (FONICAP)E Baldini, C Tibaldi, A Ardizzoni, et al.Pageof 2